# Kristin Meliambro

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kristin-meliambro/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,527 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 16 |
| i10-index | 19 |
| Last Known Institution | Icahn School of Medicine at Mount Sinai |
| OpenAlex ID | https://openalex.org/A5015100871 |
| Works | 47 |

## Researcher papers

- [Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1](https://scholariq.org/papers/lumasiran-an-rnai-therapeutic-for-primary-hyperoxaluria-type-1/)
- [Recent Progress in HIV-Associated Nephropathy](https://scholariq.org/papers/recent-progress-in-hiv-associated-nephropathy/)
- [Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure](https://scholariq.org/papers/podocyte-specific-deletion-of-yes-associated-protein-causes-fsgs-and-progressive/)
- [Association of Vaccination with the Persistence of Post-COVID Symptoms](https://scholariq.org/papers/association-of-vaccination-with-the-persistence-of-post-covid-symptoms/)
- [Acute Kidney Injury in Hospitalized Patients with COVID-19](https://scholariq.org/papers/acute-kidney-injury-in-hospitalized-patients-with-covid-19/)
- [Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis](https://scholariq.org/papers/identification-and-validation-of-urinary-cxcl9-as-a-biomarker-for-diagnosis-of/)
- [Hippo signaling in the kidney: the good and the bad](https://scholariq.org/papers/hippo-signaling-in-the-kidney-the-good-and-the-bad/)
- [Podocyte-targeted therapies — progress and future directions](https://scholariq.org/papers/podocyte-targeted-therapies-progress-and-future-directions/)
- [The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics](https://scholariq.org/papers/the-hippo-pathway-regulator-kibra-promotes-podocyte-injury-by-inhibiting-yap/)
- [Prevention of the Osmotic Demyelination Syndrome After Liver Transplantation: A Multidisciplinary Perspective](https://scholariq.org/papers/prevention-of-the-osmotic-demyelination-syndrome-after-liver-transplantation-a/)
- [Focal Segmental Glomerulosclerosis](https://scholariq.org/papers/focal-segmental-glomerulosclerosis-2/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Kidney Stones and Urolithiasis Treatments](https://scholariq.org/topics/kidney-stones-and-urolithiasis-treatments/)
- [Hippo pathway signaling and YAP/TAZ](https://scholariq.org/topics/hippo-pathway-signaling-and-yap-taz/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)

## Researcher university

- [Icahn School of Medicine at Mount Sinai](https://scholariq.org/institutions/icahn-school-of-medicine-at-mount-sinai/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
